Medical Equipment

Small Volume Parenteral Market Expansion Outlook Through 2030 With Revenue Growth Insights

May 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Small Volume Parenteral Market In 2026 And How Much Will It Reach By 2030?

The small volume parenteral market size has experienced strong growth in recent years. It is forecast to increase from $191.36 billion in 2025 to $207.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical growth can be attributed to factors such as the increasing use of injectable therapies, the expansion of hospital-based drug administration, the availability of glass ampule packaging, the growth of acute care treatments, and the rising demand for parenteral nutrition.

The small volume parenteral market is projected to experience substantial expansion over the coming years, reaching $275.99 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period is primarily due to several factors, including the escalating demand for biologics and vaccines, greater uptake of self-injectable treatments, an increase in aseptic manufacturing capabilities, a heightened emphasis on sophisticated drug delivery mechanisms, and amplified investments in sterile packaging solutions. Key developments anticipated during this timeframe involve the wider acceptance of prefilled syringe formats, a surging need for sterile injectable medications, broader application of single-dose parenterals, the expanded provision of vaccine and biologic administrations, and a sharper concentration on ensuring drug safety and stability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp

What Major Growth Factors Are Impacting The Small Volume Parenteral Market?

An escalating volume of surgical procedures is anticipated to fuel the expansion of the small-volume parenteral market in the future. Surgery, a medical discipline, encompasses the application of operative methods to examine or address a pathological state like illness or injury, enhance bodily function or aesthetics, or mend undesirable ruptured regions. The frequency of surgeries is on the rise, driven by progress in medical technology and an aging global demographic, thereby escalating the need for surgical interventions. Small-volume parenteral solutions find application in surgical settings for the precise delivery of medications, electrolytes, and essential nutrients directly into the bloodstream. As an illustration, in June 2024, data from the American Society of Plastic Surgeons, a US-based non-profit organization, indicated that minimally invasive procedures grew by 7% in 2023, surpassing the growth rate of overall surgical procedures by 2%. Furthermore, hand surgeries, including conditions like carpal tunnel, arthritis, and trigger finger, reached a total of 207,887 procedures, marking a 2% increase from 2022. Consequently, the rising count of surgeries is a key factor propelling the development of the small-volume parenteral market.

What Segment Categories Are Evaluated In The Small Volume Parenteral Market Study?

The small volume parenteral market covered in this report is segmented –

1) By Type: Ampules, Vials, Prefilled Syringes

2) By Dose Type: Single Dose, Multiple Dose

3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorders, Diabetes, Other Indications

4) By Application: Local Anesthetics, Vaccines, Other Applications

5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users

Subsegments:

1) By Ampules: Glass Ampules, Plastic Ampules

2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials

3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes

What Trends Are Shaping The Small Volume Parenteral Market Structure?

Major companies operating in the small-volume parenteral market are directing their efforts towards developing innovative solutions, including prefilled, ready-to-use injectable formulations, to enhance dosing precision, lessen the risk of contamination, and improve patient safety. These prefilled, ready-to-use injectable formulations are medicines provided already measured in a sterile syringe or vial, enabling healthcare providers to administer the drug directly without further preparation. As an example, in June 2025, Gland Pharma Limited, an India-based pharmaceutical company focused on generic injectables, received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Angiotensin II Acetate Injection 2.5 mg/mL. This injection is indicated for swiftly increasing blood pressure in adults experiencing septic or distributive shock when conventional therapies prove inadequate. It works by attaching to vascular smooth muscle receptors, inducing vasoconstriction, and promoting aldosterone release, with a rapid onset that typically reaches target blood pressure within five minutes. Administered intravenously, the dosage is precisely titrated to maintain the desired blood pressure, providing essential support for patients who remain hypotensive despite fluid resuscitation and vasopressor treatment.

Who Are The Prominent Players Across The Small Volume Parenteral Market?

Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

Access The Complete Small Volume Parenteral Market Report:

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

What Is The Largest Regional Market In The Small Volume Parenteral Market?

North America was the largest region in the small volume parenteral market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Small Volume Parenteral Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Browse Through More Reports Similar to the Global Small Volume Parenteral Market 2026, By The Business Research Company

Parenteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

Small Volume Parenteral Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Large Volume Parenteral Lvp Market Report 2026

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795